Refresh
Gainers Losers Sectors Indices Forex Mutual Funds

Arihant Institute Ltd.

Price on BSE   13 Dec,00:00 LIVE
1.56
+0.07
(+4.70%)

© 2026 Rediff.com
  • Volume :
  • 24,000.00
  • Prev Close :
  • 1.49
  • Day's H/L (Rs.) :
  • 1.56 - 1.42
  • 52wk H/L (Rs.) :
  • 2.71 - 1.34
  • Mkt Cap (Rs. Cr) :
  • 1.47
Arihant Institute Ltd. is not listed on NSE

© 2026 Rediff.com
Report Card - Arihant Institute Ltd.
PE Ratios
EPS (Rs.)
0.02
Sales (Rs. Cr)
0.05
Face Value (Rs.)
10
Net Profit Margin(%)
35.96
Last Bonus
-
Last Dividend(%)
-
Return on Average Equity
0.11

News for Service

India Real Estate: Capital Inflows Rise 72% to $5.1 Billion
Indian real estate sees record $5.1 billion capital inflow in Jan-Mar, a 72% rise. Developers & REITs drive growth despite global uncertainty.
Apr 22, 2026 11:03
Ajanta Pharma Gets USFDA Form 483 with 5 Observations
USFDA issues Form 483 with five observations to Ajanta Pharma's Paithan facility in Maharashtra after inspection. Company to respond soon.
Apr 22, 2026 10:59
Lupin Launches Anti-Diabetic Tablets in US
Lupin launches generic dapagliflozin and metformin hydrochloride extended-release tablets in the US after USFDA approval.
Apr 22, 2026 10:51
HCLTech Shares Tank After Earnings
HCLTech shares fell nearly 10% after March quarter earnings. FY27 growth guidance is 1-4%. AI revenue crosses $620M.
Apr 22, 2026 10:48
RBI Monitors FDI Outflows, Exchange Rates
RBI Governor Sanjay Malhotra closely monitors short-term fluctuations like FDI outflows and exchange rate movements. India's strong macroeconomic fundamentals highlighted.
Apr 22, 2026 10:48

More News »

Top News

India Real Estate: Capital Inflows Rise 72% to $5.1 Billion
Indian real estate sees record $5.1 billion capital inflow in Jan-Mar, a 72% rise. Developers & REITs drive growth despite global uncertainty.
Apr 22, 2026 11:03
Ajanta Pharma Gets USFDA Form 483 with 5 Observations
USFDA issues Form 483 with five observations to Ajanta Pharma's Paithan facility in Maharashtra after inspection. Company to respond soon.
Apr 22, 2026 10:59
Lupin Launches Anti-Diabetic Tablets in US
Lupin launches generic dapagliflozin and metformin hydrochloride extended-release tablets in the US after USFDA approval.
Apr 22, 2026 10:51
HCLTech Shares Tank After Earnings
HCLTech shares fell nearly 10% after March quarter earnings. FY27 growth guidance is 1-4%. AI revenue crosses $620M.
Apr 22, 2026 10:48
RBI Monitors FDI Outflows, Exchange Rates
RBI Governor Sanjay Malhotra closely monitors short-term fluctuations like FDI outflows and exchange rate movements. India's strong macroeconomic fundamentals highlighted.
Apr 22, 2026 10:48

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com